Compare Baidu Inc (BIDU) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baidu Inc vs BIO-TECHNE Corp — how do they compare? Baidu Inc trades at $110.49 (market cap $39.68B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Baidu Inc is far larger — about 3.6× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Baidu Inc pays none. Which is the better fit depends on your goals.
| BIDU | TECH | |
|---|---|---|
Market Cap | $39.68B | $11.12B |
Sector | Media | Health |
52-Week High | $162.52 | $71.38 |
52-Week Low | $85.86 | $43.31 |
Enterprise Value | $36.33B | $11.20B |
Dividend Yield | — | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baidu (BIDU) trades at $113.39, down 3.52% amid bearish technical signals and mixed fundamentals. The stock faces pressure from declining revenue and net income margins, though it maintains strong analyst support with a $161 consensus price target. Recent news highlights AI optimism from Kunlunxin's potential $50 billion Hong Kong IPO, while cash flow trends show significant investing outflows. Technical indicators show bearish moving averages with neutral oscillators, trading near key support at $112.
Baidu presents a high-risk opportunity with Wall Street maintaining bullish ratings despite recent earnings volatility. The AI pivot and potential chip unit IPO offer growth catalysts, but declining profitability and negative cash flows pose substantial risks. Investors should weigh strong balance sheet strength against execution challenges in China's competitive tech landscape.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baidu Inc
Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
